NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
Open Access
- 25 June 2015
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (10), e412-e414
- https://doi.org/10.3324/haematol.2015.129346
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trialLeukemia, 2014
- Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaBlood, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe New England Journal of Medicine, 2013
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012
- How I treat extramedullary acute myeloid leukemiaBlood, 2011
- Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2010
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid LeukemiaThe New England Journal of Medicine, 2008
- Leukemia CutisAmerican Journal of Clinical Pathology, 2008
- Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomasLeukemia, 2007
- A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutisAnnals of Hematology, 2002